INTRODUCTION {#s0}
============

The U.S. Culture Collection Network (USCCN) is a U.S. National Science Foundation-funded Research Coordination Network that has provided opportunities for culture collection curators and other interested parties to interact since 2012. In recent years, biological collection staff have expressed concern over how to act in accordance with the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity (CBD), which beginning in October 2014, placed new requirements on international collecting, research, and development based on biological organisms. While in the past, genetic resources were considered to be the shared heritage of humankind, the Nagoya Protocol requires every party (generally a country) to establish their own national legislation governing access to genetic resources with the goal of ensuring that benefits of genetic resource utilization are shared equitably with provider nations. The fact that the United States did not ratify the CBD and does not restrict access to genetic resources adds confusion to this issue. In an effort to assist U.S. living collection managers and through them, the research communities that they serve, the USCCN held a meeting in Arlington, VA, on 9 and 10 February 2017 (see [Text S1](#textS1){ref-type="supplementary-material"} in the supplemental material) and invited culture collection managers, stakeholders, and policy makers to share their insight and information and to describe developing regulations affecting the use and sharing of living genetic resources. To ensure that timely information is publicly available, this meeting report will summarize existing legislation and describe how to find information on accessing genetic resources in accordance with relevant local regulations.
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Living collections. {#s1}
-------------------

Living collections have received, characterized, preserved, and distributed biological resources and information for basic and applied research for many years ([@B1]). These collections promote reproducibility in science and provide raw material for new areas of inquiry ([@B2]). Access to living resources has been foundational to research, health care, agriculture, and industry since the beginning of the modern era of biology. Public research resources have led to developments such as the green revolution, advanced health care, including antibiotics, drugs modulating immunity, and drugs modulating human metabolism, as well as drugs for diverse applications such as production of ingredients for food, feed, and fiber, industrial chemicals and processing agents, and even household products such as laundry detergent ([@B3]). Modern biotechnology based on PCR ([@B4]) or CRISPR (clustered regularly interspaced short palindromic repeat)-Cas (CRISPR-associated system) ([@B5], [@B6]) have their origins in material sourced from public living microbe collections.

Waves of discovery parallel the exploration of new sources, beginning with macrobiota and expanding to extreme terrestrial environments ([@B7], [@B8]) and marine environments in the modern era ([@B9]). The present frontier is the exploration of genome sequences using bioinformatic approaches coupled with manipulation of gene expression ([@B10], [@B11]). Many of these approaches depend on access to validated microorganisms from public culture collections ([@B12], [@B13]) many of which began as personal research collections or as the result of systematic collecting, mutagenesis, manipulation, or taxonomic description. Other collections are public repositories that focus on a target species or clades of organisms ([@B14]). Microbial and algal collections uniquely deal with genetic resources that may transcend geopolitical divisions because they are dispersed by wind ([@B15], [@B16]) or water currents ([@B17]). Most of these collections were established prior to and grew without anticipating the requirements of international treaties. While the collecting endeavors of the 1900s and before allowed the extraction and exploitation of once geographically limited resources and led to widespread distribution of valuable plant species ([@B18]), the ratification of the CBD in 1993 began a new era of sovereign rights to genetic resources. Just as countries are recognized to have sovereignty over their mineral rights ([@B19]), the CBD assures that they also retain sovereignty over their biodiversity, even when it is utilized in another country.

THE CONVENTION ON BIOLOGICAL DIVERSITY {#s2}
======================================

While the CBD outlined the principles for access and benefit sharing, specific procedures to achieve these worthy goals were not detailed in the original treaty. For almost 20 years, countries struggled to implement legislation and agreements that determine what types of materials are covered, what documentation and permits would be required prior to collecting, transporting, and using organisms, and what types of uses would be exempt from these restrictions. In light of these challenges, parties to the CBD agreed to negotiate an international regime of access and benefit sharing which culminated in the adoption of the Nagoya Protocol at the 10th meeting of the Conference of Parties to the CBD (COP) in Nagoya, Japan, in 2010 ([@B20]).

In October 2014, the Nagoya Protocol on Access and Benefit Sharing was ratified by the required number of countries and entered into force ([@B21]). The objective of the Nagoya Protocol is to assure that access to genetic resources is associated with conservation of biodiversity and fair and equitable benefit sharing; specifically, benefits are to be shared with the country providing access to its genetic resources. Although the United States has not signed or ratified the Protocol, participants at the February 2017 USCCN meeting heard that, just like our obligation to obey any national legislation when visiting a foreign country, U.S. researchers should comply with all "access and benefit sharing" (ABS) regulations enacted by the country from which they are collecting or otherwise utilizing genetic resources. Consequences of not following established regulations could include revocation of access to genetic resources, termination of grant support, or negative attention in scientific or public literature ([@B22]). Because they depend on national legislation in the provider country, consequences could fall on the local collaborator more heavily than on U.S. researchers. The benefits received by the country of origin can be monetary, in-kind (such as training), capacity building, or (for example) coauthorship on publications. The United States does not formally restrict access to genetic resources, although local entities (such as the U.S. National Park Service, state parks, or conservation areas) or landowners may restrict access or have specific requirements for the use of genetic resources collected from their sites. Regardless of collection history or original mission, U.S. living collections that contain organisms of international origin are impacted by the CBD and the Nagoya Protocol ([@B23]).

The Access and Benefit-Sharing Clearing-House. {#s2.1}
----------------------------------------------

The Access and Benefit-Sharing Clearing-House (ABS Clearing-House \[ABSCH\]) (<https://absch.cbd.int>) hosted by the CBD Secretariat is a central repository designed to share ABS information relevant to implementation of the Nagoya Protocol. The ABSCH includes information regarding national requirements and procedures for access to genetic resources and associated traditional knowledge and the sharing of benefits arising from their use. The Nagoya Protocol requires that parties to the Protocol make available to the ABS Clearing-House information on legislative, administrative, or policy measures, national focal points, and competent national authorities responsible for providing information on how to access genetic resources and associated traditional knowledge, including how to obtain Prior Informed Consent (PIC) and establish Mutually Agreed Terms (MAT). Parties (countries) requiring PIC are required to issue a permit and register specific nonconfidential information from the permit on the ABS Clearing-House in order to constitute an Internationally Recognized Certificate of Compliance as proof that PIC, MAT, and all access requirements of the provider country have been properly met. The information gathered from a user constitutes a checkpoint to alert relevant authorities, in particular of the provider country, on how their genetic resources are being used. When fully implemented, these steps should be automatically managed by the clearinghouse mechanism ([@B24]).

NONLIVING OR ONCE-LIVING RESOURCES INCLUDING GENOME SEQUENCE INFORMATION {#s3}
========================================================================

Because of the position of tissue, DNA, or other genetic resources as the foundation to provide whole-genome sequence information, representatives of the Global Genome Biodiversity Network (GGBN) described their efforts to promote fair access to genetic resources. They emphasized that new pathways to accessing genetic resources under the Nagoya Protocol are subject to decisions by parties to the Nagoya Protocol. The second Meeting of the Parties to the Nagoya Protocol (COP/MOP 2) was held very recently (December 2016), and some issues remain to be decided. One specific area currently being considered by the Parties to the Nagoya Protocol is the status of digital sequence information as it relates to the Nagoya Protocol. A compromise proposal was adopted by COP/MOP 2, which establishes a 2-year process to consider the potential implications of digital sequence information for the three objectives of the Convention on Biological Diversity, namely, biodiversity conservation, sustainable use of biodiversity, and the fair and equitable sharing of benefits arising from the use of genetic resources. The outcomes from this process will be considered at the third Meeting of the Parties in November 2018.

Because access to pathogen specimens is essential for detecting and responding to disease outbreaks, the Nagoya Protocol discusses disease outbreaks in Article 8 as requiring special consideration. COP/MOP also discussed the status of microbial pathogen specimens, and while no formal decisions have been made, the COP/MOP requested the Secretariat to conduct a study into criteria that could be used to identify what constitutes a specialized access and benefit-sharing agreement and the process for recognizing such an instrument. The ability to develop specialized ABS instruments (exemptions) will be important to the long-term success of the Nagoya Protocol. Examples of specialized instruments being discussed include the International Treaty on Plant Genetic Resources for Food and Agriculture and the Pandemic Influenza Preparedness Framework ([@B25]).

SPECIFIC LEGISLATION {#s4}
====================

National legislation in Brazil and the European Union (EU) has already been established, and representatives of each of these parties described their national legislation at the USCCN meeting. Because they are perceived as provider and end-user parties, respectively, their very different approaches to implementation of the Nagoya Protocol provide clear examples of how to obtain necessary authorization to access and utilize genetic resources.

(i) Brazil. {#s4.1}
-----------

Brazil implemented access and benefit-sharing legislation for genetic resources and associated traditional knowledge in 2001 through the Provisional Act 2186-16/2001. After almost 15 years of experience with this legal framework, law 13.123, which provides for access to genetic resources and associated traditional knowledge and on benefit sharing for the conservation and sustainable use of biodiversity, came into force on 17 November 2015. Importantly, Brazil has taken the position that access to all genetic resources from Brazil begins not when they were collected, exported, and deposited in collections but when the research and development activities (access) take place. Because this is contrary to the perspective that the date when a specimen was first isolated or characterized is the defining date for ABS, it deserves special notice. According to the new Brazilian definitions of access to genetic resources and research, the law reaches all activities conducted with Brazilian biodiversity. These activities include research related to molecular taxonomy, phylogeny, molecular ecology, and molecular epidemiology, as well as the use of information from genetic sequences published in public databases. Thus, Brazil considers that utilization of genome sequence for the purposes of research and development is the defining time, not when the organism was identified and characterized or when the genetic information was published. Additionally, the new law stipulates that all microorganisms collected from the national territory, territorial sea, exclusive economic zone, or continental platform is part of the Brazilian genetic resources. Moreover, the law determines that foreign institutions can access Brazilian genetic resources only in partnership with a Brazilian institution and that, for all legal purposes, the Brazilian institution will be responsible for the activities of access to genetic resources. In this context, therefore, registration of access to Brazilian genetic resources is the responsibility of the collaborating Brazilian institution.

In general, the new law brings some improvements. Prior authorization procedures were replaced by electronic registration during the phase of research and technological development. This is followed by a notification process before the economic exploitation of a finished product derived from the access to genetic resources or associated traditional knowledge. Therefore, the benefit sharing occurs only when the marketing (sale) of these products take place. The registration and notification are conducted through the system developed by the Ministry of Environment National System for Genetic Heritage and Associated Traditional Knowledge Management (SisGen) by a representative of a Brazilian institution. Another novelty of the new law is in its establishment of the National Fund for Benefit Sharing (FNRB), which is linked to the Ministry of Environment. When a resource is commercialized, the user will have to deposit a defined amount of the net income acquired from the sale of the finished product. When the monetary resources deposited in FNRB arise from the economic exploitation of finished products that come from access to genetic resources obtained from *ex situ* collections, the collection will receive a defined portion of the financial resources.

(ii) The European Union. {#s4.2}
------------------------

The European Union is also a Party to the Nagoya Protocol and has developed blanket legislation that will apply to all EU member countries. The legislation, EU regulation no. 511/2014 on ABS compliance, recognizes the 12 October 2014 date of entry into force as being the relevant date after which access to genetic resources is subject to the provisions of the Nagoya Protocol. The legislation emphasizes that it is applicable to genetic resources from countries that have ratified the Nagoya Protocol, exercise sovereign rights, and have established ABS measures. Further, the regulation is applicable only when conducting research and development on the genetic and/or biochemical composition of genetic resources, including through the application of biotechnology. It does not apply to genetic resources that are already governed by specialized international instruments such as the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA), although the status of specialized instruments remains to be determined (see above).

Importantly, the focus of the EU regulations is on benefit sharing and leaves the control of access to genetic resources up to the individual member states. Some EU member states, such as the United Kingdom or Denmark, have decided not to limit access to sovereign genetic resources, and other than designating some restricted areas, do not require PIC and MAT. Countries such as France and Spain, however, are implementing regulatory control of access. Each European country will put in place implementation acts such as that in the United Kingdom where the Nagoya Protocol (Compliance) Regulations 2015 Statutory Instrument 2015 No. 821 was enacted in March 2015 (<http://www.legislation.gov.uk/uksi/2015/821/pdfs/uksi_20150821_en.pdf>). In the United Kingdom and across Europe, national authorities are supporting best practices through self-regulation tools to enable regulatory compliance. Various user communities have been invited to develop common approaches with the option for recognition by the EU Commission and Member States ([Table 1](#tab1){ref-type="table"}).

###### 

Sources of information and model documents

  Resource[^a^](#ngtab1.1){ref-type="table-fn"}                                                                                      Internet link(s)
  ---------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------
  U.S. Culture Collection Network                                                                                                    <http://www.usccn.org>
  World Federation for Culture Collections                                                                                           <http://www.wfcc.info>
  Scientific Collections International                                                                                               <http://www.scicoll.org>
  Global Genome Biodiversity Network                                                                                                 <http://www.ggbn.org/>
  Biotechnology Industry Organization (BIO), Guidelines for BIO Members Engaging in Bioprospecting, BIO Model MTA                    <https://www.bio.org/articles/bio-bioprospecting-guidelines>
  Consortium of European Taxonomic Facilities (CETAF), Code of Conduct and Best Practice for Access and Benefit Sharing              <https://www.cbd.int/abs/submissions/icnp-3/EU-Taxonomic-practices.pdf>
  ABS-Management Tool, Best Practice Standard and Handbook for Implementing Genetic Resource Access and Benefit-sharing Activities   <http://www.iisd.org/library/abs-management-tool-best-practice-standard-and-handbook-implementing-genetic-resource-access>
  Swiss Academy of Sciences, Access and Benefit Sharing Good Practice for Academic Research on Genetic Resources                     <http://www.iisd.org/pdf/2006/abs_swiss_abs_good_practice.pdf>
  Botanic Gardens Conservation International (BGCI), CBD manual for botanic gardens                                                  <https://www.bgci.org/policy/cbdmanual/>
  The Mediterranean Science Commission, CIESM Charter on ABS                                                                         <http://www.ciesm.org/marine/charter/index.php>
  The ABS Capacity Development Initiative, The ABS Agreement, Key Elements and Commentary                                            <https://chm.cbd.int/database/record/208696>
  Japan Bioindustry Association and METI, the Japanese Guidelines on Access to and Benefit Sharing of Genetic Resources              <http://www.jba.or.jp/pc/en/library/pdf/2012_guideline_access_e.pdf>
  German Science Association, DFG guideline for CBD relevant research projects                                                       <http://www.dfg.de/formulare/1_021e/1_021e.pdf>
  Micro B3, ABS Model Agreement                                                                                                      <http://biogov.uclouvain.be/staff/dedeurwaerdere/CH_Micro%20B3%20model%20agreement.pdf>
  International Union for Conservation of Nature (IUCN), An Explanatory Guide to the Nagoya Protocol on Access and Benefit-sharing   <https://www.cbd.int/abs/side-events/icnp2/iucn-explanatory-guide-en.pdf>
  Microbial Resource Research Infrastructure (MIRRI) Best Practice Manual on Access and Benefit Sharing                              <http://www.mirri.org/fileadmin/mirri/media/Dokumente/MIRRI_ABS_Manual__web.pdf>

Organization and/or document(s).

Additionally, to enable due diligence, the European Commission will develop a list of biological collections with registered status. The Member States are responsible for considering inclusion and verification of these collections; however, the requirements and responsibilities of such a status have limited the number of culture collections engaging in this process. The advantage of accessing resources from a registered collection is that users of genetic resources will be considered as having exercised "due diligence" if they source their genetic resources from these registered collections. The procedural requirements for the registration of collections of genetic resources (Article 5 of the EU ABS Regulation) are set out in the Implementing Regulation.

While not specifically linked to the registered collection approach, leaders in the EU culture collection community are developing a consortium of microbial collections in the EU. Building upon the success of their Global Biological Resource Center Network demonstration project ([@B26]), they have worked to develop the network of collections under the EU Framework 7 and call this network the Microbial Resources Research Infrastructure (MIRRI) ([@B27]). Taking advantage of existing codes such as MOSAICC (Micro-Organisms Sustainable use and Access regulation International Code of Conduct), they have developed an ABS policy that focuses on the operations of a typical microbial biological resource center (according to the Organisation for Economic Co-operation and Development \[OECD\] guidelines) ([@B28]). Their recommended best practices are translated into practice and supported by community-based interpretations tested with policy makers and regulators. The MIRRI ABS policy provides mechanisms of compliance from accession to supply, model documents such as material accession agreements (MAA) and material transfer agreements (MTA), and provides a decision tree to indicate when activities are in the scope of the protocol and the steps needed to be compliant. In addition to the MIRRI ABS Manual, many other best-practices guides are available ([Table 1](#tab1){ref-type="table"}).

(iii) Partner organizations and efforts. {#s4.3}
----------------------------------------

As a nongovernmental observer at the Meeting of the Parties to the Nagoya Protocol, Scientific Collections International provided a perspective on managing access to genetic information based on living and once-living collections. Similarly, the Ecological Society of America has engaged on this topic and will hold workshops later in 2017 and 2018 to share information on the Nagoya Protocol with leaders of scientific societies as a conduit to their membership. The American Phytopathological Society has been a leader in issues related to living microbe collections ([@B29]) and also provides administrative support to the USCCN.

The World Federation for Culture Collections (WFCC) has served as a venue for interaction among culture collections for nearly 70 years. As such, living microbe collections have the benefit of a history of codes of conduct to ensure fair and equitable access to genetic resources. Beginning with the MOSAICC code of conduct that was a response to the Bonn Guidelines on access to genetic resources and the fair and equitable sharing of benefits arising out of their utilization adopted under the framework of the CBD in 2002 ([@B30]), culture collections now have the benefit of the Transparent User-friendly System of Transfer for Science and Technology (TRUST), which is an updated code of conduct for sharing microbial resources. TRUST relies on a demonstrated chain of custody and requires collections to document where they received materials from and where they sent those materials. Among the presentations at the February 2017 meeting was a demonstration of how TRUST could facilitate microbial utilization in collaboration with CBD and the World Data Centre for Microorganisms ([@B31]).

U.S. COLLECTIONS AND THE NAGOYA PROTOCOL {#s5}
========================================

Many U.S. collections hold materials that were isolated within the sovereign boundaries of another country ([Table 2](#tab2){ref-type="table"}), and the status of individual strains may depend on yet-to-be enacted national legislation in the provider country. Many collections hold large numbers of isolates that were collected and deposited prior to the ratification of the CBD or the Nagoya Protocol. The Fungal Genetics Stock Center (FGSC), for example, holds more than 500 strains that were collected around the world prior to 1993 ([Table 2](#tab2){ref-type="table"}). Other resources are isolated in common areas such as the open ocean, and they have unique legal status ([@B32]). Many U.S. research resource collections hold genetically characterized model organism strains with various histories such as strains that were isolated in the early classical genetic era, genetically crossed, mutagenized, and modified by various molecular genetic techniques ([@B33][@B34][@B35]).

###### 

Holdings and distribution of participating genetic resources in the United States[^a^](#ngtab2.1){ref-type="table-fn"}

  Collection name                                          Acronym   No. of strains                                                                                                             
  -------------------------------------------------------- --------- ---------------- -------------------------------------------- -------- ----- --------------------------------------------- --------------------------------------------
  Fungal Genetics Stock Center                             FGSC      26,000           568                                          1,800    600   21,551                                        9,504
  The Mollicutes Collection                                TMC       988              337                                          90       33    30                                            14
  Bloomington Drosophila Stock Center                      BDSC      59,915           7,929                                        58,060   214   109,792                                       107,603
  Center for Forest Mycology Research Culture Collection   CFMR      13,241           2,200                                        7,730    30    10,327                                        2,633
  Centre for Agriculture and Biosciences International     CABI      30,000           28,330                                       12,750   11    112                                           16,800
  *E. coli* Genetic Stock Center                           CGSC      10,000           0                                            6,927    8     43,741                                        42,438
  Phaff Yeast Culture Collection                           UCDFST    7,581            2,759                                        2,508    132   6,202[^b^](#ngtab2.2){ref-type="table-fn"}    1,285[^b^](#ngtab2.2){ref-type="table-fn"}
  National Center for Marine Algae and Microbiota          NCMA      2,648            1,751[^c^](#ngtab2.3){ref-type="table-fn"}   1,803    20    711                                           457
  UTEX Culture Collection of Algae                         UTEX      3,026            1,300                                        1,030    10    18,265[^b^](#ngtab2.2){ref-type="table-fn"}   6,505[^b^](#ngtab2.2){ref-type="table-fn"}

Data are since 1993 for collections participating in the 2017 USCCN meeting.

Distribution data since 2006.

Includes strains without geographic origin information or from international waters.

Additional U.S. collections described at the February 2017 USCCN meeting included a freshwater alga collection (UTEX Culture Collection of Algae) ([@B36]), a cave microbe collection (University of Akron) ([@B7]), and a biodiversity collection of yeasts (Phaff Yeast Culture Collection, University of California, Davis) ([@B37]). These collections hold diverse resources used in genetic, biodiversity, and industrial biotechnology research. Of these collections, the FGSC is primarily a research resource repository serving a specific research community by holding and managing classical genetic and gene deletion mutant strains, in addition to nearly 5,000 wild-type strains isolated in nature around the world. While classical and targeted genetic mutants are primarily research tools, their importance was recently reemphasized by the inability to recapitulate phenotypes seen in zebra fish gene suppression lines using mutant lines generated with molecular tools such as CRISPR-Cas ([@B38]).

Among the biodiversity collections described at the meeting, the collection of cave microbes held at the University of Akron has special provenance. Originally isolated in caves managed by the U.S. National Park Service, these strains will ultimately be distributed through the American Type Culture Collection as a special collection (<http://www.cavescience.com/>). Other collections represented at the meeting include the U.S. Department of Agriculture (USDA) Agriculture Research Service (ARS) Culture Collection (Peoria, IL), the USDA ARS security back-up collection (Fort Collins, CO), which holds more than 111,000 microbial isolates from 20 different U.S. culture collections, the Bloomington Drosophila Stock Center (Bloomington, IN), the USDA Forest Service's Center for Forest Mycology Research collection (Madison, WI), and The Mollicutes Collection of Cultures and Antisera (Gainesville, FL).

EXISTING PRACTICES {#s6}
==================

To allow comparison and establish precedent, participants at the February 2017 meeting shared their accession and distribution practices. It was clear that this was an area where each collection's practices reflected the historical role of each collection as well as the types of material in the collection ([Table 2](#tab2){ref-type="table"}). Historical biodiversity collections and research resource collections often have very simple accession and transfer requirements, while formal government collections often have more-formal MTA agreements ([@B39]). The terminology for accession and distribution contracts was very different for different types of collections. The fact that most living collections can distribute materials while keeping the original distinguishes them from other types of collections. Efforts to develop best practices for sharing invertebrate biological control organisms acknowledge that living microbial genetic resources for biocontrol have unique issues relating to the Nagoya Protocol ([@B40]).

MICROBIAL GENETIC RESOURCES AND A MICROBIAL COMMONS {#s7}
===================================================

The dinner talk provided history on the development of the Nagoya Protocol beginning with the Bonn Declaration ([@B41]) and continuing through the current protocol. The talk emphasized the context of the CGIAR (Consultative Group for International Agricultural Research) system and their participation in the multilateral system of access and benefit sharing developed as part of the International Treaty on Plant Genetic Resources for Food and Agriculture (ITPGRFA) ([@B42]). In this context, the potential advantages of a "Microbial Commons" with predefined multilateral access and benefit-sharing guidelines were presented. This approach is considered in paragraphs 12 and 16 of the EU regulation no. 511/2014 which also recognizes that the ITPGRFA ([@B43]) and the Pandemic Influenza Preparedness Framework ([@B44]) are consistent with the Nagoya Protocol. The flexibility in the Nagoya Protocol, including Articles 4 and 20, enable the recognition of the practices of the microbial sector, such as the TRUST code of conduct or the Pandemic Influenza Preparedness Framework ([@B25]). Article 19 on model contractual clauses recognizes the advantage of having standardized contracts such as those developed by microbial collections for deposit and distribution of material, the Material Accession (or Deposit) Agreement and the Material Transfer Agreement, respectively. This is an area of intense discussion and negotiation, as national legislation develops in countries around the world ([@B45]).

SUMMARY {#s8}
=======

Although the United States did not ratify the CBD and is not a signatory to the Nagoya Protocol, this international agreement does affect U.S. scientists. The Nagoya Protocol provides countries with a framework to implement one of the three objectives of the CBD, namely, the fair and equitable sharing of benefits arising out of the utilization of genetic resources. The Nagoya Protocol sets out core obligations for its contracting parties to take measures in relation to access to genetic resources, benefit sharing, and compliance, which may impact the requirements for collecting, transporting, and using microbes of international origin. The specific terms vary by country of origin, including what organisms are covered, what uses are restricted, and what agreements and permits must be obtained. Information on ABS procedures and requirements continue to emerge as the parties enact national regulations. Curators and customers of U.S. biological collections are encouraged to refer to the Access and Benefit-Sharing Clearing-House website for updated information on emerging legislation and regulations that apply to the use of living biological diversity.

Contribution no. 17-345-J from the Kansas Agricultural Experiment Station.
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